Products - Diabetes | Topic | NICE

Showing 98 products

Date | Sort by Title

Diabetes (type 1 and type 2) in children and young people: diagnosis and management (NG18)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
31 March 2022
Published:
1 August 2015
Type 1 diabetes in adults: diagnosis and management (NG17)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
31 March 2022
Published:
26 August 2015
Type 2 diabetes in adults: management (NG28)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
31 March 2022
Published:
2 December 2015
3C Patch for treating diabetic foot ulcers (MTG66)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
7 March 2022
Diabetes in pregnancy: management from preconception to the postnatal period (NG3)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
16 December 2020
Published:
25 February 2015
Ranibizumab for treating diabetic retinopathy (terminated appraisal) (TA637)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
30 June 2020
Sotagliflozin with insulin for treating type 1 diabetes (TA622)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
12 February 2020
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (TA613)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
20 November 2019
Diabetic foot problems: prevention and management (NG19)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
11 October 2019
Published:
26 August 2015
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes (TA583)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
5 June 2019
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 March 2019
The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
25 March 2019
Published:
25 March 2014
Neuropad for detecting preclinical diabetic peripheral neuropathy (MTG38)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
10 September 2018
Type 2 diabetes: prevention in people at high risk (PH38)
Product type:
Guidance
Programme:
Public health guideline
Last updated:
15 September 2017
Published:
12 July 2012
Dapagliflozin in combination therapy for treating type 2 diabetes (TA288)
Product type:
Guidance
Programme:
Technology appraisal guidance
Last updated:
23 November 2016
Published:
26 June 2013
Dapagliflozin in triple therapy for treating type 2 diabetes (TA418)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
23 November 2016
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (TA390)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 May 2016
Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system) (DG21)
Product type:
Guidance
Programme:
Diagnostics guidance
Published:
12 February 2016
Aflibercept for treating diabetic macular oedema (TA346)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
22 July 2015
Dexamethasone intravitreal implant for treating diabetic macular oedema (TA349)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
22 July 2015
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes (IPG518)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 March 2015
Empagliflozin in combination therapy for treating type 2 diabetes (TA336)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 March 2015
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy (MTG22)
Product type:
Guidance
Programme:
Medical technologies guidance
Last updated:
1 March 2015
Published:
31 December 2014
Canagliflozin in combination therapy for treating type 2 diabetes (TA315)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 June 2014
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (TA301)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 November 2013
Ranibizumab for treating diabetic macular oedema (TA274)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 February 2013
Type 2 diabetes prevention: population and community-level interventions (PH35)
Product type:
Guidance
Programme:
Public health guideline
Published:
10 May 2011
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy (IPG274)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 September 2008
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
23 July 2008
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus (IPG257)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 April 2008
d-Nav insulin management app for type 2 diabetes (MIB285)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
8 February 2022
AI technologies for detecting diabetic retinopathy (MIB265)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
6 July 2021
Dexcom G6 for real-time continuous glucose monitoring (MIB233)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
3 November 2020
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes (MIB227)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
22 September 2020
Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema (MIB144)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
24 April 2018
Health app: GDm-Health for people with gestational diabetes (MIB131)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
13 November 2017
FreeStyle Libre for glucose monitoring (MIB110)
Product type:
Advice
Programme:
Medtech innovation briefing
Last updated:
29 September 2017
Published:
3 July 2017
Aptiva for painful diabetic neuropathy (MIB119)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
13 September 2017
MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes (MIB51)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
12 February 2016
Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) (ESNM64)
Product type:
Advice
Programme:
Evidence summary
Published:
2 December 2015
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM65)
Product type:
Advice
Programme:
Evidence summary
Published:
2 December 2015
Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)
Product type:
Advice
Programme:
Evidence summary
Published:
13 October 2015
Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)
Product type:
Advice
Programme:
Evidence summary
Published:
3 July 2015
Type 2 diabetes: dulaglutide (ESNM59)
Product type:
Advice
Programme:
Evidence summary
Published:
16 June 2015
Type 2 diabetes: insulin degludec (ESNM25)
Product type:
Advice
Programme:
Evidence summary
Published:
10 September 2013
Diabetes in children and young people (QS125)
Product type:
Quality standard
Last updated:
31 March 2022
Published:
14 July 2016
Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups (QS167)
Product type:
Quality standard
Published:
11 May 2018
Diabetes in adults (QS6)
Product type:
Quality standard
Last updated:
18 August 2016
Published:
30 March 2011
Diabetes in pregnancy (QS109)
Product type:
Quality standard
Published:
19 January 2016
Diabetes (type 1 and type 2) in children and young people: diagnosis and management – periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Type 1 diabetes in adults: diagnosis and management – periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Type 2 diabetes in adults: management - periodontal disease
Status:
In development
Programme:
NICE guideline
Expected publication date:
29 June 2022
Finerenone for treating chronic kidney disease in people with type 2 diabetes [ID3773]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
6 June 2022
Expected publication date:
14 September 2022
Dexamethasone intravitreal implant for treating diabetic macular oedema in people without a pseudophakic lens [ID3951]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
14 September 2022
Brolucizumab for treating diabetic macular oedema [ID3902]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
16 November 2022
Diabetic foot problems: prevention and management (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
18 January 2023
Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
3 January 2024
Diabetic retinopathy
Status:
In development
Programme:
NICE guideline
Expected publication date:
3 April 2024
Diabetic retinopathy - ruboxistaurin [ID382]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Macular oedema (diabetic) - pegaptanib sodium [ID452]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Diabetes - buccal insulin [ID311]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Empagliflozin for reducing the risk of cardiovascular events in type 2 diabetes [ID1037]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for treating type 2 diabetes (ID1450)
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Dulaglutide for treating type 2 diabetes [ID1451]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Diabetes update
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sotagliflozin for treating type 2 diabetes [ID1657]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Faricimab for treating diabetic macular oedema [ID3899]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Tirzepatide for treating type 2 diabetes ID3938
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Diabetes in pregnancy (update)
Status:
In development
Expected publication date:
TBC
Type 1 and Type 2 diabetes in adults (update)
Status:
In development
Expected publication date:
TBC
Type 2 diabetes in adults (update)
Status:
In development
Expected publication date:
TBC
Teplizumab for delaying the onset of type 1 diabetes in people 8 years and over at risk of developing the condition TS ID 10753
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Diabetes in adults update - Type 1 and Type 2
Status:
In development
Expected publication date:
TBC
Type 2 diabetes in adults: management (medicines update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC
Community based approaches to addressing high blood pressure with black African and Caribbean men
Product type:
Shared learning
Published:
13 August 2021
Help to Care Mobile App: Supporting care workers and carers to identify and prevent deterioration
Product type:
Shared learning
Published:
9 September 2020
Ambulatory Acute Foot Service - Royal Free London NHS FT
Product type:
Shared learning
Published:
20 January 2020
Tackling the overtreatment of type 2 diabetes in frail older people through individualising care in East Sussex: a pharmacist led project
Product type:
Shared learning
Published:
17 September 2019
Development of Black and minority ethnic (BME) patient-centred dietary resources to improve hyperkalaemia in chronic kidney disease patients
Product type:
Shared learning
Published:
28 March 2019
Improving foot care outcomes for people with diabetes in Wessex
Product type:
Shared learning
Published:
22 March 2019
Turning the tide on ineffective prescribing of glucagon like peptide (GLP-1) mimetics in type 2 diabetes in East Sussex
Product type:
Shared learning
Published:
29 November 2018
A language specific and culturally adapted pain management programme
Product type:
Shared learning
Published:
14 May 2018
Young Adult Diabetes: Engaging to improve; outcomes of the young adult clinic restructure
Product type:
Shared learning
Published:
3 April 2018
Supporting the management of type 2 diabetes with pharmacist-led reviews and implementing NICE recommended nine key care processes
Product type:
Shared learning
Published:
12 February 2018
NICE Fellowship project to facilitate the implementation of NICE guidance PH38 via the utilisation of Tier 2 and Tier 3 weight management and lifestyle-intervention programmes for the prevention of type 2 diabetes
Product type:
Shared learning
Published:
14 November 2017
Implementing an active foot disease pathway for people with diabetes in South Tees
Product type:
Shared learning
Published:
1 July 2016
Implementing multiple daily injection insulin regimens (MDI) with carbohydrate counting for children and young people at diagnosis of type 1 diabetes: education provided by the Children’s Diabetes Service for patients, families and staff
Product type:
Shared learning
Published:
6 April 2016
Training non-podiatrists to assess foot risk as part of an integrated foot service for people with diabetes
Product type:
Shared learning
Published:
16 February 2016
PITstop training and the use of NICE guidance and the Type 2 diabetes treatment pathway
Product type:
Shared learning
Published:
29 July 2014
Establishing a Multi-disciplinary Diabetes Stakeholder Network: Early results
Product type:
Shared learning
Published:
20 June 2014
Using a Quality Improvement Framework to make local population health gains
Product type:
Shared learning
Published:
30 November 2012
An innovative approach to providing lifestyle education and behaviour change to prevent type 2 diabetes
Product type:
Shared learning
Published:
26 June 2012
Walking Away from Type 2 Diabetes: implementation of a diabetes prevention programme
Product type:
Shared learning
Published:
1 June 2012
Establishing a children's insulin pump service in Leeds
Product type:
Shared learning
Published:
10 February 2009